Clinical Trials on Keratosis in Austria

Total 117 results

Medical University of Vienna

Terminated

Imiquimod Versus Photodynamic Therapy of Actinic Keratoses in Organ Transplant Recipients (AKtransplant)

Actinic Keratoses

Austria
Medical University of Graz

Completed

Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream

Actinic Keratoses

Austria
Biofrontera Bioscience GmbH

Completed

Study to Evaluate the Safety of BF-200 ALA (Ameluz®) for Photodynamic Therapy (PDT) in the Treatment of Expanded Fields of Actinic Keratosis (AK)

Actinic Keratoses

United States
Peplin

Completed

Pharmacokinetic Study to Evaluate the Extent of Systemic Absorption of PEP005

Actinic Keratoses

Australia
Galderma R&D

Completed

Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses (CoMet)

Actinic Keratoses

Australia
Spirig Pharma Ltd.

Terminated

Prevention of UV-induced Carcinogenic Skin Alterations in Immunosuppressed Solid Organ Transplanted Patients

Actinic Keratoses | Squamous Cell Carcinomas

Ireland, Austria, Netherlands, United Kingdom, Czech Republic, France, Germany, Switzerland, Turkey
Peplin

Completed

A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations

Actinic Keratoses

United States, Australia
Peplin

Completed

A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations

Actinic Keratoses

United States
Graceway Pharmaceuticals, LLC

Completed

Safety and Effectiveness Study of Imiquimod Creams for Treatment of Actinic Keratoses (AKs)

Actinic Keratoses

United States
Actavis Inc.

Completed

Bioequivalence of Generic Imiquimod Cream, 5% When Compared to Aldara™ (Imiquimod) Cream, 5% in the Treatment of Actinic Keratosis

Actinic Keratoses

United States
Encube Ethicals Pvt. Ltd.
Novum Pharmaceutical Research Services

Completed

Therapeutic Equivalence of Diclofenac Sodium Gel 3% vs Solaraze ® in the Treatment of Actinic Keratosis

Actinic Keratoses

United States
Actavis Mid-Atlantic LLC

Completed

A Bioequivalence Study With Clinical Endpoints Comparing Generic Imiquimod Cream, 3.75% and Zyclara™ (Imiquimod) Cream, 3.75% in Subjects With Actinic Keratoses

Actinic Keratoses

United States
Peplin

Completed

A Study to Determine the Optimal Tolerated Regime and Safety of PEP005 Topical Gel

Actinic Keratoses

Australia, New Zealand
Clinuvel Pharmaceuticals Limited

Unknown

Phase II AK Study in Organ Transplant Patients

Carcinoma, Squamous Cell | Actinic Keratoses | Organ Transplant Recipients

Australia, Sweden, Switzerland, Italy, France, Belgium, Germany
Galderma R&D

Completed

Multicenter Study to Assess the Efficacy and Safety of Methyl Aminolevulinate Hydrochloride (MAL) 16.8% Cream (CD06809-41) Versus Vehicle Cream for Actinic Keratosis of the Face

Actinic Keratoses

United States, Puerto Rico
Medical University of Graz

Completed

Tirbanibulin 1% Ointment for the Treatment of Chronically Sun-damaged Skin on the Face (SunDamage)

Actinic Keratosis

Austria
Aclaris Therapeutics, Inc.

Completed

Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis

Seborrheic Keratosis (SK)

United States
Peplin

Completed

Study to Evaluate the Safety and Efficacy of PEP005(Ingenol Mebutate) Gel, 0.05%, in Patients With Seborrhoeic Keratosis

Seborrheic Keratosis

Australia
Johannes Kepler University of Linz

Recruiting

Validation of Interleukins and Other Cytokines Together With OCT Imaging for Rapid Infectious Keratitis Assessment (VICTORIA)

Keratitis Bacterial | Keratitis Fungal

Austria
Peplin

Completed

Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Actinic Keratoses

Actinic Keratosis

Australia
LEO Pharma

Completed

Safety and Dose Finding Study of New Vehicle Formulations Containing Ingenol Mebutate to Treat Actinic Keratosis on the Forearm

Actinic Keratosis

Australia
Premier Specialists, Australia
The University of New South Wales

Active, not recruiting

Evaluation of the Responsiveness of Investigator Global Assessment Score for Keratosis Pilaris

Keratosis Pilaris

Australia
Athenex, Inc.

Completed

Ph 1, Single-Center, Safety, Tolerability & Pharmacokinetic Study of KX2 391 Ointment in Subj. w Actinic Keratosis

Actinic Keratosis

United States
Peplin

Completed

A Study to Evaluate the Pharmacokinetics of PEP005 (Ingenol Mebutate) Gel, 0.05%, When Applied in a Maximal Use Setting to the Dorsal Aspect of the Forearm in Patients With Actinic Keratosis

Actinic Keratosis

United States
LEO Pharma

Completed

Safety and Tolerability of Different Concentrations of an Ingenol Derivative Field Therapy in the Treatment of Actinic Keratosis

Actinic Keratosis

Australia
Peplin

Completed

A Long Term Follow up Study of Patients Who Have Completed the PEP005-020 Study

Actinic Keratosis

United States, Australia
Novartis Pharmaceuticals

Completed

Safety, Tolerability, and Efficacy Study of LFX453 in Actinic Keratosis Patients

Actinic Keratosis

Germany, Denmark, United Kingdom, Iceland, Austria
Peplin
TKL Research, Inc.

Completed

A Multi-center Study to Evaluate the Safety and Efficacy of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on Non-head Locations (Trunk and Extremities)

Actinic Keratosis

United States, Australia
Aclaris Therapeutics, Inc.

Completed

Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis

Seborrheic Keratosis

United States
LEO Pharma

Completed

Histological Confirmation of Clinical Clearance of Actinic Keratoses Following Treatment With Ingenol Mebutate Gel, 0.05%

Actinic Keratosis

Australia, Germany
Aclaris Therapeutics, Inc.

Completed

An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses (SK-FAN)

Seborrheic Keratosis

United States
Aclaris Therapeutics, Inc.

Completed

Study of A-101 for the Treatment of Seborrheic Keratosis

Seborrheic Keratosis

United States
MEDA Pharma GmbH & Co. KG
Accovion GmbH; Siro Clinpharm Germany GmbH (until June 2013)

Completed

Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2) (LEIDA 2)

Actinic Keratosis

Austria, Germany
DUSA Pharmaceuticals, Inc.

Completed

Maximal Use Systemic Exposure Study of Levulan Kerastick (MUSE 2)

Keratosis, Actinic

United States
Aclaris Therapeutics, Inc.

Completed

A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic Keratosis

Seborrheic Keratosis

United States
Peplin

Completed

Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2

Actinic Keratosis

United States, Australia
Peplin

Completed

A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)

Actinic Keratosis

United States, Australia
Galderma R&D
Parexel

Completed

Metvix Daylight PDT in Actinic Keratosis (SESAME)

Actinic Keratosis

Spain, United Kingdom, Australia, France, Italy, Netherlands, Switzerland
Galderma R&D

Completed

Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp

Actinic Keratosis

United States
DUSA Pharmaceuticals, Inc.

Completed

Levulan PDT Versus Vehicle for Extremity Actinic Keratoses (AK)

Keratosis, Actinic

United States
Peplin

Completed

A Multicenter Study to Evaluate the Safety and Efficacy of PEP005 Topical Gel When Used to Treat Actinic Keratoses on the Head (Face or Scalp)

Actinic Keratosis

United States, Australia
DUSA Pharmaceuticals, Inc.

Completed

Maximal Use Systemic Exposure (MUSE) Study of Levulan Kerastick

Keratosis, Actinic

United States
MEDA Pharma GmbH & Co. KG

Completed

Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA)

Actinic Keratosis

Austria, Germany, France
DUSA Pharmaceuticals, Inc.

Withdrawn

Phase 3 Study of Levulan With New Blue Light for AK on the Face or Scalp

Actinic Keratosis

United States
Premier Specialists, Australia

Recruiting

Development and Validation of an Investigator Global Assessment Score for Keratosis Pilaris

Keratosis Pilaris

Australia
Dr. Reddy's Laboratories Limited

Completed

A Study to Evaluate Two Concentrations of DFD-07 Cream, in Subjects With Actinic Keratosis (AK) of the Face and/or Scalp Over a 12-week Treatment Period

Actinic Keratosis (AK)

United States
Peplin
TKL Research, Inc.

Completed

A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies

Actinic Keratosis

United States, Australia
Peplin

Completed

A Long Term Follow up Study of Patients Who Have Complete Clearance of Their Actinic Keratosis (AK) Lesions at the Day 57 Visit in the PEP005-028 Study

Actinic Keratosis

United States
LEO Pharma

Completed

Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp

Actinic Keratosis

Canada, Germany, Australia, France, United Kingdom
DUSA Pharmaceuticals, Inc.

Completed

Short-incubation Levulan Photodynamic Therapy Versus Vehicle for Face/Scalp Actinic Keratosis (AK)

Actinic Keratosis

United States

3

Subscribe